Cargando…
Ensemble of structure and ligand-based classification models for hERG liability profiling
Drug-induced cardiotoxicity represents one of the most critical safety concerns in the early stages of drug development. The blockade of the human ether-à-go-go-related potassium channel (hERG) is the most frequent cause of cardiotoxicity, as it is associated to long QT syndrome which can lead to fa...
Autores principales: | Vittorio, Serena, Lunghini, Filippo, Pedretti, Alessandro, Vistoli, Giulio, Beccari, Andrea R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076575/ https://www.ncbi.nlm.nih.gov/pubmed/37033661 http://dx.doi.org/10.3389/fphar.2023.1148670 |
Ejemplares similares
-
Early identification of hERG liability in drug discovery programs by automated patch clamp
por: Danker, Timm, et al.
Publicado: (2014) -
An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020) -
Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers
por: Wang, Yiwei, et al.
Publicado: (2020) -
Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010) -
Voltage-Dependent Gating of hERG Potassium Channels
por: Cheng, Yen May, et al.
Publicado: (2012)